Fierce Pharma
AUGUST 30, 2024
As a new deadly strain of mpox continues its global spread, Emergent BioSoultion's smallpox vaccine ACAM2000 has officially joined the ranks of FDA-approved defense measures against the virus. | With the nod, Emergent's vaccine joins Bavarian Nordic's Jynneos as approved protection options to address the continued outbreak in Africa, which was recently deemed a public health emergency.
Pharma IQ
AUGUST 30, 2024
Understand the potential of AI to unlock the comprehensive value of health data and transform the healthcare sector.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
AUGUST 30, 2024
Hutchmed, the original developer of Takeda’s Fruzaqla, has decided not to pursue an approval for the VEGFR inhibitor in stomach cancer for now in its home country. | Hutchmed, the original developer of Takeda’s Fruzaqla, has decided not to pursue an approval for the VEGFR inhibitor in stomach cancer in its home country for now thanks to doubts around patients’ overall survival.
MedCity News
AUGUST 30, 2024
Providers should carefully evaluate how different AI models can be strategically integrated to optimize the care management lifecycle and address the complex needs of their patients and populations, while at the same time prioritizing patient safety and ethical considerations. The post Overcoming the Challenges of Integrating AI in Care Management appeared first on MedCity News.
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
Fierce Pharma
AUGUST 30, 2024
After a regulatory hiccup earlier this month, Novo Nordisk’s heart failure ambitions for its obesity star Wegovy (semaglutide) are starting to get back on track. | Novo’s semaglutide cut the risk of combined cardiovascular death or worsening heart failure events by 31%, based on an incident rate of 5.4% in semaglutide patients versus 7.5% in those on placebo, the company said Friday.
MedCity News
AUGUST 30, 2024
The speaker roster for the September 18 conference spans industry experts in cybersecurity, healthcare investment, AI for drug development, diagnostic testing, and more. The post Who is Speaking at MedCity INVEST Digital Health in Dallas? appeared first on MedCity News.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
MedCity News
AUGUST 30, 2024
Here is a selection of recent executive hires, retirements, promotions and layoffs occurring across the healthcare industry. The post Healthcare Moves: A Monthly Summary of Hires and Layoffs appeared first on MedCity News.
Fierce Pharma
AUGUST 30, 2024
Alnylam is circling the bases after walloping—in the words of chief medical officer Pushkal Garg M.D.—a “grand slam” with data that position its RNA silencer Amvuttra (vutrisiran) to potentially be | At the European Society of Cardiology conference in London, Alnylam presented positive data from the phase 3 HELIOS-B trial which assessed RNA silencer Amvuttra (vutrisiran) as a treatment for transthyretin amyloid cardiomyopathy (ATTR-CM).
MedCity News
AUGUST 30, 2024
In this month’s episode, Senior Reporter Katie Adams explored some of the executive moves and layoffs that recently occurred in the healthcare world. She also interviewed Graham Barnes, who just stepped into a new role as the CEO of Medically Home. The post MedCity Moves Podcast: Recent Hires, Layoffs & an Interview with Graham Barnes, CEO of Medically Home appeared first on MedCity News.
pharmaphorum
AUGUST 30, 2024
Emergent BioSolutions has been given FDA approval to extend the indications for its smallpox vaccine ACAM2000 to include the prevention of mpox, currently deemed a public health emergency by the WHO.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
MedCity News
AUGUST 30, 2024
Expanding the diversity of our mental health workforce is crucial, but it’s a long-term goal that won’t address the immediate needs we’re facing today. We need solutions now to bridge the gap between demand and access. The post Mental Healthcare in Underserved Populations is in Crisis and It’s Not Just a Provider Resource Problem appeared first on MedCity News.
pharmaphorum
AUGUST 30, 2024
Troubled UK biotech ReNeuron will cancel its AIM listing, saying it has been unable to raise the funds it needs to bring it out of administration
MedCity News
AUGUST 30, 2024
Through a new partnership, Hinge Health members receiving movement-based menopause support will also be able to access clinical care from Midi Health. The post Hinge Health, Midi Health Strike Partnership for Women Experiencing Menopause appeared first on MedCity News.
Pharmaceutical Commerce
AUGUST 30, 2024
The latest news for pharma industry insiders.
Advertisement
Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten
pharmaphorum
AUGUST 30, 2024
BioMarin wields axe again, slashing 225 positions from its global workforce as it continues a major restructuring drive
Pharmaceutical Technology
AUGUST 30, 2024
US Congress labelled pharmacy benefit managers (PBMs) as ‘anticompetitive’; PBMs blame manufacturers for increasing pharmaceutical prices.
pharmaphorum
AUGUST 30, 2024
J&J files FcRn blocker nipocalimab for generalised myasthenia gravis (gMG) in US, setting up a challenge to rival drugs from Argenx and UCB
MedCity News
AUGUST 30, 2024
Emergent BioSolutions’ smallpox vaccine, ACAM2000, now has an additional FDA approval covering mpox. It’s one of two FDA-approved mpox vaccines, joining Jynneos from Bavarian Nordic. The post FDA Approves Emergent BioSolutions Vaccine as New Tool in Fight Against Mpox appeared first on MedCity News.
Pharmacy Times
AUGUST 30, 2024
The request comes as increased scrutiny is levied toward pharmacy benefit managers for alleged unfair business practices.
MedCity News
AUGUST 30, 2024
Check out news from Oral Genome, BeMe Health, Noetik, and Vouched. The post StartUPDATES: New Developments from Healthcare Startups appeared first on MedCity News.
Pharmacy Times
AUGUST 30, 2024
Shared clinical decision-making presented drawbacks, resulting in age-based recommendations for adults aged 75 years and older and risk-based recommendations for individuals aged 60-74 years.
Pharmaceutical Technology
AUGUST 30, 2024
J&J’s BLA was supported by data from the Phase III VIVACITY study, demonstrating the safety and efficacy of biweekly nipocalimab.
Advertisement
Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.
PharmaTech
AUGUST 30, 2024
The approach makes use of clinical mass spectrometers that are already available in hospitals around the world.
Pharmaceutical Technology
AUGUST 30, 2024
If approved, Novo Nordisk's Ozempic will become the first GLP-1 therapy option for patients with type 2 diabetes and chronic kidney disease.
PharmExec
AUGUST 30, 2024
Submission is supported by results from the Phase III Vivacity-MG3 study, which demonstrated that nipocalimab, combined with standard care, significantly improved outcomes for patients with antibody-positive generalized myasthenia gravis.
Pharmaceutical Technology
AUGUST 30, 2024
Experts discuss the relationship between obesity and heart failure while referencing new clinical trial results.
PharmaTech
AUGUST 30, 2024
Ecolab is looking to the future with new opportunities to partner with Pharma for critical solutions to support drug development and manufacturing.
Pharmaceutical Technology
AUGUST 30, 2024
Alnylam announced positive final results from the Helios-B trial for patients with ATTR amyloidosis with cardiomyopathy at the ESC Congress.
Pharmaceutical Commerce
AUGUST 30, 2024
The company also participated in the coalition’s pilot inspection program, making it the first CDMO to do so.
PharmExec
AUGUST 30, 2024
Ecolab is looking to the future with new opportunities to partner with Pharma for critical solutions to support drug development and manufacturing.
Advertisement
Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A
Expert insights. Personalized for you.
306 
Let's personalize your content